Petros Plots Next Point On OTC ED Switch Path: Stendra Self-Selection Study

Two weeks after announcing strong results from label comprehension study, initiating self-selection study using Drug Facts label tested for nonprescription sales of its ED drug Stendra.

• Source: Shutterstock

More from Rx-to-OTC Switch

More from Health